Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEPress Release▲ PositiveExpansion3d ago

Cohance Lifesciences Limited

Press Release

Cohance Lifesciences Limited has announced two proposed transactions to strengthen its Antibody-drug Conjugate (ADC) strategy: an additional investment of USD 13 million in NJ Bio and a controlling investment of USD 5 million in Aruka Bio.

Read more →📎 1 attachment
BSECompany Update▲ PositiveRating Change3d ago

Aarti Surfactants Ltd

Upward Revision in Credit Rating

Aarti Surfactants Ltd has transitioned its credit rating agency from CARE Ratings Limited to CRISIL Ratings Limited, with CRISIL Ratings upgrading the company's long-term bank loan facilities to Crisil A-/ Stable from CARE BBB+.

Read more →📎 1 attachment
NSECredit Rating- Revision▲ PositiveRating Change3d ago

Cemindia Projects Limited

Credit Rating- Revision

Cemindia Projects Limited has informed the Exchange about Credit Rating- Revision, with ICRA Limited upgrading its credit ratings to [ICRA]AA (Stable) for Fund-Based Facilities and Non-Fund-Based Facilities.

Read more →📎 1 attachment
BSEAGM/EGM▲ PositiveResults3d ago

Yash Highvoltage Ltd

Proceedings of Annual General Meeting 2025-2026

Yash Highvoltage Ltd held its Annual General Meeting (AGM) on September 3, 2026, through video conferencing. The meeting was attended by 50 members representing 57.47% of the company's equity shares. The company reported a strong FY 2025-26 with revenue growth of 57% to ₹235 crore, EBITDA growth of 74% to ₹60 crore, and Profit After Tax growth of 75% to ₹37 crore.

Read more →📎 1 attachment
NSECredit Rating- Revision▲ PositiveRating Change3d ago

Cemindia Projects Limited

Credit Rating- Revision

Cemindia Projects Limited has informed the Exchange about Credit Rating- Revision by CARE Ratings Limited, upgrading its credit ratings to CARE AA-; Stable from CARE A+; Stable for various facilities.

Read more →📎 1 attachment
BSEOthers▲ PositiveM&A3d ago

Cohance Lifesciences Ltd

Outcome of Committee Meeting

Cohance Lifesciences Ltd has announced two proposed transactions to strengthen its Antibody-drug Conjugate (ADC) strategy, investing USD 13 million in NJ Bio and USD 5 million in Aruka Bio, increasing its stake in NJ Bio from 56% to 67.3% and acquiring a controlling stake in Aruka Bio.

Read more →📎 1 attachment
NSECommittee Meeting Updates▲ PositiveM&A3d ago

Cohance Lifesciences Limited

Committee Meeting Updates

Cohance Lifesciences Limited has informed the Exchange regarding Outcome of Committee Meeting held on September 03, 2026, where the Investment, Banking and Authorisations Committee (IBA Committee) has approved the acquisition of additional shares in NJ Bio and a controlling investment in Aruka Bio to strengthen its Antibody-drug Conjugate (ADC) strategy.

Read more →📎 1 attachment
BSEOthers▲ PositiveResults3d ago

Rajesh Power Services Ltd

Annual Report of Financial year 2025-26

Rajesh Power Services Ltd, an engineering company, has released its annual report for FY 2025-26, showcasing a 52% increase in revenue to ₹1628 crore and a 59% rise in EBITDA to ₹197 crore. The company's operational capabilities and project execution expertise have strengthened its position in the power infrastructure sector.

Read more →📎 1 attachment
BSEOthers▲ PositiveResults3d ago

Fractal Industries Ltd

Annual Report - 2025-26

Fractal Industries Ltd has released its Annual Report for 2025-26, showcasing a strong financial performance with revenue growth of +5.08% and EBITDA growth of +57.31%. The Company has expanded its role across the apparel ecosystem, developed a proprietary brand, and established a closer connection with the end consumer.

Read more →📎 1 attachment
NSEPress Release▲ PositiveJoint Venture3d ago

Avalon Technologies Limited

Press Release

Avalon Technologies Limited has formed a joint venture with Zollner Elektronik AG for advanced electronics manufacturing in India, expanding Avalon's access to global customers and adding new industry verticals.

Read more →📎 1 attachment
BSEOthers▲ PositiveResults3d ago

Star Cement Ltd

Annual Report for the Financial Year 2025-26 is attached.

Star Cement Ltd has submitted its Annual Report for the Financial Year 2025-26, along with the Notice of its 25th Annual General Meeting, scheduled to be held on September 25, 2026. The report highlights the company's transformation into a broader pan-India player, with operational improvements, expanded market reach, and strengthened supply responsiveness. The company has declared an interim dividend of ₹2 per share.

Read more →📎 1 attachment
NSEPress Release▲ PositiveOrder Win3d ago

Solex Energy Limited

Press Release

Solex Energy Limited has received work orders worth ₹74.77 crore for solar PV modules, with an additional Letter of Intent (LOI) for an order worth ₹174.30 crore. The orders are scheduled for execution by December 2026, strengthening the company's order pipeline and reflecting continued demand for its solar module manufacturing capabilities.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults3d ago

Indigo Paints Ltd

Earnings Call Transcript

Indigo Paints Ltd has announced its Q1 FY27 earnings, with revenue growing in double digits and volumes also increasing across the product portfolio. The company's gross margin stood at 45.3% and EBITDA margin at 17.7%, both ahead of the listed paint companies' average.

Read more →📎 1 attachment